Pacifica Partners’s Korro Bio KRRO Stock Holding History

Pacifica Partners’s Portfolio KRRO Stock Details KRRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-4	Closed	-$2K	–	484
2021 Q1	$2K	Hold	4	–	–	﹤0.01%	378
2020 Q4	$7K	Buy	+4	New	+$5.28K	0.01%	281

Other funds holding KRRO

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SDIC

South Dakota Investment Council Sioux Falls, South Dakota $5.24B AUM 22.1% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LOAMS

Lombard Odier Asset Management (Switzerland) Petit-Lancy, Switzerland $2.63B AUM 31.52% 1-Year Est. Return

Pacifica Partners's KRRO Position: Q2 2021 in Review

Pacifica Partners sold out of Korro Bio (KRRO) in Q2 2021, closing a stake of 4 shares — an estimated $2K sold.

Pacifica Partners first reported a position in KRRO in Q4 2020 and held it in 2 quarters. The position peaked at $7K in Q4 2020. 91 funds tracked by Wall St. Rank hold KRRO as of Q2 2021.

Pacifica Partners reported no remaining Korro Bio position as of Q2 2021 after selling out during the quarter.
Pacifica Partners sold 4 Korro Bio shares in Q2 2021, an estimated $2K.
Pacifica Partners first reported a position in Korro Bio in Q4 2020 and held it in 2 quarters.
Pacifica Partners's Korro Bio position peaked at $7K in Q4 2020.
91 funds tracked by Wall St. Rank held Korro Bio as of Q2 2021.

Based on Pacifica Partners's 13F filing for Q2 2021, filed 14 Jul 2021.